Alzheimer's drug benefits 'too small' to offer on NHS, NICE finds
By Lee Peart 19 June 2025
The benefits from Alzheimer’s drugs donanemab and lecanemab are too small to justify the additional costs to the NHS, NICE has found.
Public Health & Noise and Nuisance Officer
£42,771 - £46,968
Barnet (City/Town), London (Greater)£42,771 - £46,968
Most Read News
- 'We will not cut NHS budgets to fund this,' Streeting assures on US pharma deal
- 'Unacceptably long waiting times' found for adult gender services
- Trust ordered to pay £450k for race discrimination and unfair dismissal
- 'Deep concerns' over fitness to practise case delays
- BREAKING NEWS: Mental Health Bill receives Royal Assent
Public Health & Noise and Nuisance Officer
£42,771 - £46,968
Barnet (City/Town), London (Greater)£42,771 - £46,968
Most Read News
- 'We will not cut NHS budgets to fund this,' Streeting assures on US pharma deal
- 'Unacceptably long waiting times' found for adult gender services
- Trust ordered to pay £450k for race discrimination and unfair dismissal
- 'Deep concerns' over fitness to practise case delays
- BREAKING NEWS: Mental Health Bill receives Royal Assent
©2024 Hemming Group Limited. Registered in England and Wales. Registered No: 490200. VAT number GB342 023 408
